Scholar : Amyloid, Volume 24, Issue 3, September 2017 is now available online on Taylor & Francis Online

The online platform for Taylor & Francis Online content Amyloid, Volume 24, Issue 3, September 2017 is now available online on Taylor & Francis Online. This new issue contains the following articles: Commentary Artificial neural network modelling of ATTR amyloidosis: is now the time? John L. Berk Pages: 141-142 | DOI: 10.1080/13506129.2017.1345732 Review Article Mining databases for protein aggregation: a review Paraskevi L. Tsiolaki , Katerina C. Nastou , Stavros J. Hamodrakas & Vassiliki A. Iconomidou Pages: 143-152 | DOI: 10.1080/13506129.2017.1353966 Original Article Applying an artificial neural network model for developing a severity score for patients with hereditary amyloid polyneuropathy Shenia Novis, Felipe Machado, Victor B. Costa, Debora Foguel, Marcia W. Cruz & José Manoel de Seixas Pages: 153-161 | DOI: 10.1080/13506129.2017.1343714 Changing epidemiology of AA amyloidosis: clinical observations over 25 years at a single national referral centre Thirusha Lane, Jennifer H. Pinney, Janet A. Gilbertson, David F. Hutt, Dorota M. Rowczenio, Shameem Mahmood, Sajitha Sachchithanantham, Marianna Fontana, Taryn Youngstein, Candida C. Quarta, Ashutosh D. Wechalekar, Julian D. Gillmore, Philip N. Hawkins & Helen J. Lachmann Pages: 162-166 | DOI: 10.1080/13506129.2017.1342235 Towards the improvement in stability of an anti-Aβ single-chain variable fragment, scFv-h3D6, as a way to enhance its therapeutic potential Laia Montoliu-Gaya, Javier Murciano-Calles, Jose C. Martinez & Sandra Villegas Pages: 167-175 | DOI: 10.1080/13506129.2017.1348347 Kidney biopsy in AA amyloidosis: impact of histopathology on prognosis Zeynep Kendi Celebi, Saba Kiremitci, Bengi Ozturk, Serkan Akturk, Siyar Erdogmus, Neval Duman, Kenan Ates, Sehsuvar Erturk, Gokhan Nergizoglu, Sim Kutlay, Sule Sengul, Arzu Ensari & Kenan Keven Pages: 176-182 | DOI: 10.1080/13506129.2017.1350158 Predictors of early treatment failure following initial therapy for systemic immunoglobulin light-chain amyloidosis Nidhi Tandon , Surbhi Sidana, S. Vincent Rajkumar, Angela Dispenzieri, Morie A. Gertz, Martha Q. Lacy, Robert A. Kyle, Francis K. Buadi, David Dingli, Suzanne R. Hayman, Amie L. Fonder, Miriam A. Hobbs, Wilson I. Gonsalves, Prashant Kapoor, Yi Lisa Hwa, Nelson Leung, Ronald S. Go, John A. Lust, Stephen J. Russell, Steven R. Zeldenrust & Shaji K. Kumar Pages: 183-188 | DOI: 10.1080/13506129.2017.1351354 Safety and efficacy of empirical interleukin-1 inhibition using anakinra in AA amyloidosis of uncertain aetiology Thirusha Lane, Ashutosh D. Wechalekar, Julian D. Gillmore, Philip N. Hawkins & Helen J. Lachmann Pages: 189-193 | DOI: 10.1080/13506129.2017.1352503 Long-term safety and efficacy of tafamidis for the treatment of hereditary transthyretin amyloid polyneuropathy: results up to 6 years | Fabio A. Barroso, Daniel P. Judge, Ben Ebede, Huihua Li, Michelle Stewart, Leslie Amass & Marla B. Sultan Pages: 194-204 | DOI: 10.1080/13506129.2017.1357545 Novel pathologic scoring tools predict end-stage kidney disease in light chain (AL) amyloidosis Samuel Rubinstein, Robert F. Cornell, Liping Du, Beatrice Concepcion, Stacey Goodman, Shelton Harrell, Sara Horst, Daniel Lenihan, David Slosky, Agnes Fogo & Anthony Langone Pages: 205-211 | DOI: 10.1080/13506129.2017.1360272 To update which email alerts you receive, manage your alerts within the My Account area. You can also unsubscribe from this alert with one click. If you need any further help, please contact us at support@tandfonline.com Please do not reply to this email. To ensure that you receive your alerts and information from Taylor & Francis Online, please add "alerts@tandfonline.com" and "info@tandfonline.com" to your safe senders list. Taylor & Francis, an Informa business. Taylor & Francis is a trading name of Informa UK Limited, registered in England under no. 1072954. Registered office: 5 Howick Place, London, SW1P 1WG.